Choosing the intensity of PF stimulation more carefully might therefore allow selectivity for cerebellar pathways.
In the case of GLV-1h153, inactivatiof of the thymidine kinase (TK) gene, for example, makes the replication more dependent on host cell TK for deoxyribonucleotide synthesis, which may allow for increased selectivity of viral replication for malignant neoplasms [ 12, 13].
Some added benefits of this study are that the tight controllability of these reactors may allow for increased reaction selectivity, energy efficiency, and reduced pollution levels.
This selectivity may allow the use of STACs in the treatment of SIRT1-dependent metabolic diseases while avoiding some of the adverse pro-oncogenic effects of p53 deacetylation and destabilization.
The formation of heterotrimeric non-apoptotic TRAIL receptor complexes and the receptor binding promiscuity of TRAIL endorsed the concept that DR selectivity may allow the creation of more potent TRAIL apoptosis inducers.
However, their high selectivity and tumoricidal capabilities may allow for optimal therapy in vivo at low therapeutic concentrations, potentially limiting any side effects associated with them [ 23].
The challenge with the use of inhibitors to examine phenotypic consequences is obtaining specific inhibition of the kinase of interest, since it is unlikely that absolute kinase selectivity will be achieved, which may allow confounding phenotype(s).
Therefore, unlike inhibiting Plk1 KD, antagonizing the PBD function may allow one to uniquely impose an additional layer of selectivity in killing cancer cells, but not normal cells.
This may allow Softbank a dignified exit.
These features combined, may allow the use of the described method for a large-scale study of ligand and binding-site promiscuity determinants, and potentially, the prediction of ligand selectivity in prospective scenarios based on topological similarity profiles.
For example, exploring topoisomerase II isozyme selectivity, investigating the sensitivity and resistance of topoisomerase II mutants to voreloxin and analogs, and possibly mapping the sites of drug enzyme interaction may allow further optimization of topoisomerase II-targeting therapeutics to enhance clinical benefit.
